Keyphrases
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
100%
Dapagliflozin
100%
Diabetic Cardiomyopathy
100%
Inflammation
37%
Angiotensin II (Ang II)
37%
Db Mouse
37%
Heart Failure
25%
Fibrosis
25%
Cardioprotection
25%
Diabetic Mice
25%
Cardiomyopathy
25%
Diabetes Mellitus Type 2
25%
Isolated Cardiomyocytes
25%
Sodium-glucose Transporter 2 Inhibitors
25%
Intracellular Calcium Transient
25%
Risk Factors
12%
Reduced Oxygen
12%
Potential Therapeutics
12%
Kidney
12%
Cardiovascular Prevention
12%
Clinical Data
12%
Toll-like Receptor 4 (TLR4)
12%
Patient-specific Therapy
12%
Drinking Water
12%
ROS Production
12%
Diabetic Mouse Model
12%
Blood Glucose
12%
Indo-1
12%
Oxygen Radicals
12%
Pharmacologic
12%
Voltage Dependence
12%
Therapeutic Benefits
12%
Membrane Transporters
12%
Membrane Channels
12%
Protection Mechanism
12%
Ion Homeostasis
12%
Developing Heart
12%
Systolic Function
12%
Myocardial Fibrosis
12%
Sodium-hydrogen Exchanger
12%
Osmotic Pump
12%
Left Ventricular End-diastolic Diameter
12%
Cardiovascular Effects
12%
Fluorescent Indicator
12%
Transporter Expression
12%
Cardiac Hypertrophy
12%
Calcium Transport
12%
Angiotensin II Infusion
12%
Subcutaneous Infusion
12%
Diabetic Heart Disease
12%
Diabetic Drugs
12%
CACNA1C
12%
L-type Calcium Channel
12%
Transient Production
12%
Sodium-calcium Exchanger
12%
Myocardial Inflammation
12%
Event Failure
12%
Pharmacology, Toxicology and Pharmaceutical Science
Sodium Glucose Cotransporter 2 Inhibitor
100%
Dapagliflozin
100%
Diabetic Cardiomyopathy
100%
Db/Db Mouse
50%
Angiotensin II
50%
Inflammation
37%
Non Insulin Dependent Diabetes Mellitus
25%
Heart Failure
25%
Sodium Glucose Cotransporter 2
25%
Fibrosis
25%
Cardiomyopathy
25%
Mouse
12%
Mouse Model
12%
Oxygen Radical
12%
Tumor Necrosis Factor
12%
Indo 1
12%
Heart Muscle Fibrosis
12%
Heart Ventricle Hypertrophy
12%
Toll Like Receptor 4
12%
Sodium Calcium Exchange Protein
12%
Calcium Channel L Type
12%
Sodium Proton Exchange Protein 1
12%
Diabetes Mellitus
12%
Subcutaneous Injection
12%
Myocarditis
12%